Anti-Factor I/CFI antibody [EPR23948-48] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Complement Factor I antibody. Carrier free. Suitable for IP, WB and reacts with Human samples.
View Alternative Names
IF, CFI, Complement factor I, C3B/C4B inactivator
- IP
Lab
Immunoprecipitation - Anti-Factor I/CFI antibody [EPR23948-48] - BSA and Azide free (AB278530)
This data was developed using ab278524, the same antibody clone in a different buffer formulation.
Factor I/CFI was immunoprecipitated from 0.35 mg HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate 10 ug with ab278524 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab278524 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate 10 ug
Lane 2 : ab278524 IP in HepG2 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of abid in HepG2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 76 seconds.
All lanes:
Immunoprecipitation - Anti-Factor I/CFI antibody [EPR23948-48] (<a href='/en-us/products/primary-antibodies/factor-i-cfi-antibody-epr23948-48-ab278524'>ab278524</a>)
Predicted band size: 66 kDa
Observed band size: 50-88 kDa
false
- WB
Lab
Western blot - Anti-Factor I/CFI antibody [EPR23948-48] - BSA and Azide free (AB278530)
This data was developed using ab278524, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Factor I/CFI is a glycoprotein, and de-glycosylation resulted in a decrease of MW (lanes 2 and 4). Different band sizes of CFI heavy chain in liver and HepG2 lysates (lanes 1 and 3) observed may be caused by different glycosylation levels.
Exposure time : 26 seconds.
All lanes:
Western blot - Anti-Factor I/CFI antibody [EPR23948-48] (<a href='/en-us/products/primary-antibodies/factor-i-cfi-antibody-epr23948-48-ab278524'>ab278524</a>) at 1/1000 dilution
Lane 1:
Human liver tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate treated with PNGase F at 20 µg
Lane 3:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HepG2 whole cell lysate treated with PNGase F at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/2000 dilution
Predicted band size: 66 kDa
Observed band size: 40 kDa,50 kDa,75 kDa,88 kDa
false
- WB
Lab
Western blot - Anti-Factor I/CFI antibody [EPR23948-48] - BSA and Azide free (AB278530)
This data was developed using ab278524, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The molecular weight observed is consistent with what has been described in the literature (PMID : 17597211).
Low expression : A549 (PMID : 17548110).
Exposure time : Lanes 1-3 : 15 seconds; Lanes 4-6 : 5.5 seconds.
All lanes:
Western blot - Anti-Factor I/CFI antibody [EPR23948-48] (<a href='/en-us/products/primary-antibodies/factor-i-cfi-antibody-epr23948-48-ab278524'>ab278524</a>) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Human liver tissue lysate at 40 µg
Lane 4:
Human lung tissue lysate at 40 µg
Lane 5:
Human small intestine tissue lysate at 40 µg
Lane 6:
Human plasma at 10 µL
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 66 kDa
Observed band size: 50-88 kDa
false
Reactivity data
Product details
ab278530 is the carrier-free version of ab278524.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Factor I plays a role in maintaining immune homeostasis by preventing excessive complement activation. It acts within a complex that includes cofactors such as Factor H Complement Factor 4 binding protein (C4BP) and Membrane Cofactor Protein (MCP). These interactions allow Factor I to selectively degrade activated complement components ensuring that complement activity is kept in check to avoid host cell damage.
Pathways
Factor I operates in both the classical and alternative complement pathways. In the classical pathway it regulates C3b and C4b breakdown to control the formation of the C3 convertase. In the alternative pathway Factor I works in conjunction with Factor H to degrade C3b. This regulation is important to prevent runaway activation protecting healthy tissue from complement-mediated damage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com